Figure 2
From: Loss of BMI-1 expression is associated with clinical progress of malignant melanoma
Immunoreactivity for BMI-1 in cutaneous melanoma of vertical growth phase, showing (a) strong and (b) negative protein expression for the F6 antibody.
Figure 2 | Modern Pathology
